By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Blueprint Medicines 

Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-585-2033 Fax: n/a



Company News
Blueprint Medicines To Present At Wedbush 2014 Life Sciences Management Access Conference 8/6/2014 8:48:59 AM
Blueprint Medicines Appoints Jeffrey Albers As Chief Executive Officer 7/24/2014 8:13:41 AM
Blueprint Medicines To Present At JMP Securities Healthcare Conference 6/20/2014 8:20:47 AM
Blueprint Medicines Presents Positive Data On First Selective FGFR4 Inhibitor 4/7/2014 9:22:08 AM
Blueprint Medicines To Present On The First Isoform Selective FGFR4 Inhibitor At The American Association for Cancer Research Annual Meeting 2014 3/25/2014 9:12:37 AM
Blueprint Medicines To Present At Upcoming Investor Conferences 3/21/2014 8:45:36 AM
Blueprint Medicines To Present At 32nd Annual J.P. Morgan Healthcare Conference 1/9/2014 6:59:02 AM
Blueprint Medicines Reels In $25 Million For Cancer Drug Push 1/8/2014 8:20:16 AM
Personal Genome Diagnostics and Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 5/21/2013 10:23:50 AM
Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor 5/8/2012 10:35:15 AM